Medroxyprogesterone Acetate Starting Dose for Hypersexual Behavior
For managing hypersexual behavior in men, start with oral medroxyprogesterone acetate (MPA) at 60 mg daily, which can be titrated upward to 100-400 mg daily based on clinical response.
Dosing Algorithm
The evidence supports a stepwise approach to MPA dosing for hypersexual behavior:
Initial Dosing
- Start at 60 mg/day orally 1
- This lower dose has demonstrated efficacy in reducing paraphilic fantasies and behaviors while minimizing side effects
- Testosterone levels typically decrease by 50-75% (to 100-400 ng/dL range) at this dose 1
Dose Escalation
If inadequate response after 2-4 weeks:
- Titrate upward to 100-400 mg/day based on behavioral response 2
- In elderly men with dementia and inappropriate hypersexuality, the average effective dose was 300 mg/day (range 100-400 mg/day) 2
- 70% of patients responded favorably at these higher doses 2
Alternative Intramuscular Dosing
For patients requiring parenteral therapy or with compliance issues:
- 400 mg intramuscularly weekly is the standard depot dose 3, 4
- This route is FDA-approved for other indications at 400-1000 mg weekly 5
Key Clinical Considerations
Treatment Duration: Expect to continue therapy for at least 15 months on average, though some patients require years of treatment 1. The 18% reoffense rate while on MPA versus 58% in untreated controls demonstrates the need for sustained therapy 3.
Monitoring Requirements:
- Baseline and periodic testosterone levels (target 50-75% reduction from baseline)
- Blood pressure monitoring
- Weight and metabolic parameters (diabetes risk)
- Liver function tests
Important Caveats and Pitfalls
Significant Side Effects at Higher Doses: The evidence reveals concerning adverse effects, particularly at doses ≥300 mg/day, including:
- Excessive weight gain and metabolic syndrome
- Cushing's syndrome and adrenal insufficiency (documented at 300 mg/day) 6
- Hypertension, diabetes mellitus, gallstones 3
- Severe leg cramps, malaise, migraine headaches 3
Rebound Hypersexuality: Abrupt discontinuation can trigger hypersexual reactions 6, so taper gradually if stopping therapy.
Risk Stratification: Patients with elevated baseline testosterone, history of head injury, substance abuse, or "regressed" (versus "fixated") paraphilia patterns have higher reoffense rates and may require more aggressive dosing 3.
Consider Alternative Agents: Given the significant side effect profile, particularly at higher doses, GnRH agonists may be preferable alternatives with more benign safety profiles 6, though oral MPA at 60 mg/day represents a reasonable first-line approach given its demonstrated efficacy with minimal side effects at this dose 1.
Prior Treatment Failures: In the elderly dementia population, 70% had failed serotonergic agents and 40% had failed both serotonergic agents and antipsychotics before MPA was initiated 2, suggesting MPA should be considered when first-line psychotropic medications prove ineffective.